N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cells

[1]  S. Kasper,et al.  Prognosis and Improved Outcomes in Major Depression: A Review. , 2020, Focus.

[2]  A. Nadjar,et al.  Brain eicosapentaenoic acid metabolism as a lead for novel therapeutics in major depression , 2020, Brain, Behavior, and Immunity.

[3]  I. Kurtser,et al.  Activation of WNT and CREB signaling pathways in human neuronal cells in response to the Omega-3 fatty acid docosahexaenoic acid (DHA) , 2019, Molecular and Cellular Neuroscience.

[4]  R. McIntyre,et al.  Efficacy of omega-3 PUFAs in depression: A meta-analysis , 2019, Translational Psychiatry.

[5]  Christofer Thomas,et al.  Glial pathology in neuropsychiatric disorders: a brief review , 2019, Journal of basic and clinical physiology and pharmacology.

[6]  M. Fava,et al.  Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial. , 2019, JAMA psychiatry.

[7]  R. F. Campbell,et al.  Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders. , 2019, Journal of medicinal chemistry.

[8]  S. Kasper,et al.  Prognosis and improved outcomes in major depression: a review , 2019, Translational Psychiatry.

[9]  F. Gage,et al.  Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons , 2019, Molecular Psychiatry.

[10]  Roy H. Perlis,et al.  Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning , 2019, Nature Neuroscience.

[11]  Xuemei Bai,et al.  Inhibition of Necroptosis Rescues SAH-Induced Synaptic Impairments in Hippocampus via CREB-BDNF Pathway , 2019, Frontiers in Neuroscience.

[12]  Q. Rainer,et al.  Anxiolytic- and Antidepressant-Like Effects of Fish Oil-Enriched Diet in Brain-Derived Neurotrophic Factor Deficient Mice , 2018, Front. Neurosci..

[13]  P. Das,et al.  Treatment-resistant depression: problematic illness or a problem in our approach? , 2018, British Journal of Psychiatry.

[14]  Z. Bai,et al.  Omega-3 polyunsaturated fatty acids and reduction of depressive symptoms in older adults: A systematic review and meta-analysis. , 2018, Journal of affective disorders.

[15]  Moitreyi Das,et al.  Docosahexaenoic Acid (DHA) Induced Morphological Differentiation of Astrocytes Is Associated with Transcriptional Upregulation and Endocytosis of β2-AR , 2018, Molecular Neurobiology.

[16]  Young-Min Park,et al.  Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder , 2018, Psychiatry investigation.

[17]  M. Rasenick,et al.  NMDAR-independent, cAMP-dependent antidepressant actions of ketamine , 2018, Molecular Psychiatry.

[18]  Kenji F. Tanaka,et al.  Anti-Depressant Fluoxetine Reveals its Therapeutic Effect Via Astrocytes , 2018, EBioMedicine.

[19]  Ji-Hong Liu,et al.  An astroglial basis of major depressive disorder? An overview , 2017, Glia.

[20]  N. K. Popova,et al.  Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders , 2017, Reviews in the neurosciences.

[21]  L. Studer,et al.  Pluripotent stem cells in neuropsychiatric disorders , 2017, Molecular Psychiatry.

[22]  E. Castrén,et al.  Neuronal plasticity and neurotrophic factors in drug responses , 2017, Molecular Psychiatry.

[23]  J. Sangiovanni,et al.  Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression , 2016, British Journal of Psychiatry.

[24]  A. Carvalho,et al.  Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies. , 2016, Journal of affective disorders.

[25]  Hailou Zhang,et al.  PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine , 2016, Scientific Reports.

[26]  N. Morioka,et al.  Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia , 2016, Brain Research.

[27]  R. Churchill,et al.  ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review , 2016, BMJ Open.

[28]  Yongsoon Park,et al.  N-3 polyunsaturated fatty acids and 17β-estradiol injection induce antidepressant-like effects through regulation of serotonergic neurotransmission in ovariectomized rats. , 2015, The Journal of nutritional biochemistry.

[29]  A. Nierenberg,et al.  Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof of Concept Study , 2015, Molecular Psychiatry.

[30]  S. Mccarroll,et al.  Characterization of Bipolar Disorder Patient-Specific Induced Pluripotent Stem Cells from a Family Reveals Neurodevelopmental and mRNA Expression Abnormalities , 2014, Molecular Psychiatry.

[31]  E. Domenici,et al.  Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. , 2014, The international journal of neuropsychopharmacology.

[32]  J. Wan,et al.  Concise Review: Regulation of Stem Cell Proliferation and Differentiation by Essential Fatty Acids and Their Metabolites , 2014, Stem cells.

[33]  M. Szyf,et al.  Astrocytic abnormalities and global DNA methylation patterns in depression and suicide , 2014, Molecular Psychiatry.

[34]  J. Mann,et al.  Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder. , 2014, The international journal of neuropsychopharmacology.

[35]  P. Blier,et al.  Monoamine neurocircuitry in depression and strategies for new treatments , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  M. Banasr,et al.  From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders , 2013, Biological Psychiatry.

[37]  M. Rasenick,et al.  G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids. , 2013, CNS & neurological disorders drug targets.

[38]  Gustavo Turecki,et al.  Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. , 2013, Journal of psychiatry & neuroscience : JPN.

[39]  M. Rao,et al.  Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions , 2013, Stem cells.

[40]  R. Hen,et al.  BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities , 2013, Translational Psychiatry.

[41]  M. Nilsson,et al.  Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes , 2013, Acta Neuropathologica.

[42]  Jialin C. Zheng,et al.  Characterization of Induced Neural Progenitors from Skin Fibroblasts by a Novel Combination of Defined Factors , 2013, Scientific Reports.

[43]  M. Rasenick,et al.  N-3 Poly-Unsaturated Fatty Acids Shift Estrogen Signaling to Inhibit Human Breast Cancer Cell Growth , 2012, PloS one.

[44]  A. Czurkó,et al.  Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide , 2012, PloS one.

[45]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[46]  W. Fu,et al.  Role of AC-cAMP-PKA Cascade in Antidepressant Action of Electroacupuncture Treatment in Rats , 2012, Evidence-based complementary and alternative medicine : eCAM.

[47]  S. Tufik,et al.  The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: A possible antidepressant mechanism , 2012, Neuropharmacology.

[48]  M. First,et al.  Structured Clinical Interview for DSM-III-R Personality Disorders , 2012 .

[49]  Paul J. Harrison,et al.  A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder. , 2011, Journal of affective disorders.

[50]  Trina E. Chang,et al.  Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire. , 2011, The Journal of clinical psychiatry.

[51]  K. Hashimoto,et al.  Potential Role of Brain-Derived Neurotrophic Factor in Omega–3 Fatty Acid Supplementation to Prevent Posttraumatic Distress after Accidental Injury: An Open-Label Pilot Study , 2011, Psychotherapy and Psychosomatics.

[52]  P. Magistretti,et al.  Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes , 2011, Psychopharmacology.

[53]  Konstantinos Lefkimmiatis,et al.  The {omega}-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a "store-operated" mechanism. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[54]  K. Behar,et al.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole , 2010, Molecular Psychiatry.

[55]  M. Rasenick,et al.  Chronic Treatment with Escitalopram but Not R-Citalopram Translocates Gαs from Lipid Raft Domains and Potentiates Adenylyl Cyclase: A 5-Hydroxytryptamine Transporter-Independent Action of This Antidepressant Compound , 2010, Journal of Pharmacology and Experimental Therapeutics.

[56]  M. Takebayashi,et al.  Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production , 2008, Brain Research.

[57]  S. Chiou,et al.  Antidepressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2. , 2007, Current neurovascular research.

[58]  J. Blendy.  The Role of CREB in Depression and Antidepressant Treatment , 2006, Biological Psychiatry.

[59]  R. Elias,et al.  Positive Acute-Phase Inflammatory Markers in Different Stages of Chronic Kidney Disease , 2006, American Journal of Nephrology.

[60]  T. Itoh,et al.  Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. , 2004, European journal of pharmacology.

[61]  A. Baba,et al.  Increase by FK960, a novel cognitive enhancer, in glial cell line-derived neurotrophic factor production in cultured rat astrocytes. , 2004, Biochemical pharmacology.

[62]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[63]  I. Lucki,et al.  cAMP Response Element-Binding Protein Is Essential for the Upregulation of Brain-Derived Neurotrophic Factor Transcription, But Not the Behavioral or Endocrine Responses to Antidepressant Drugs , 2002, The Journal of Neuroscience.

[64]  S. Finkbeiner.  CREB Couples Neurotrophin Signals to Survival Messages , 2000, Neuron.

[65]  W. Lee,et al.  Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene. , 1999, Brain research. Molecular brain research.

[66]  K. Seamon,et al.  Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha. , 1994, Biochemistry.

[67]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[68]  M. Rasenick,et al.  Fish oil and depression: The skinny on fats. , 2017, Journal of integrative neuroscience.

[69]  M. Popoli.  Agomelatine , 2009, CNS drugs.

[70]  R. Duman,et al.  Administration of a cAMP Phosphodiesterase 4 Inhibitor Enhances Antidepressant-Induction of BDNF mRNA in Rat Hippocampus , 2000, Neuropsychopharmacology.

[71]  W. Fleischhacker,et al.  A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. , 1992, Neuropsychobiology.